ONCOPEPTIDES AB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.013 SEK | +1.96% |
|
-14.99% | -60.38% |
| 04-15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
| 04-04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
Chart calendar Oncopeptides AB
06a2ab.Bapbm3ZhaKs1fqAKOCPMRI7a-FD2nbB9AXB4ZnzsQzY.bN0d2UFXH5paNcxjYFuFPraslmWZ5Ig1aiY5AhifdmA34mjcNCcv9HQN-Q~6a1eb76473a9ade2d6ba7f8ffe70d4a5
Upcoming events on Oncopeptides AB
Past events on Oncopeptides AB
| 20/03/2024 10:30 | Redeye Theme: Commercialization in Life Science |
| 27/02/2024 08:00 | Q4 2023 Earnings Call |
| 27/02/2024 07:00 | Q4 2023 Earnings Release |
| 24/01/2024 12:07 | Redeye Theme: Fight Cancer |
| 08/11/2023 08:00 | Q3 2023 Earnings Call |
| 08/11/2023 07:00 | Q3 2023 Earnings Release |
| 10/08/2023 08:00 | Q2 2023 Earnings Call |
| 10/08/2023 07:00 | Q2 2023 Earnings Release |
| 25/05/2023 14:00 | Annual General Meeting |
| 04/05/2023 08:00 | Q1 2023 Earnings Call |
| 04/05/2023 07:00 | Q1 2023 Earnings Release |
| 16/02/2023 08:00 | FY 2022 Earnings Call |
| 16/02/2023 07:00 | FY 2022 Earnings Release |
| 09/12/2022 | American Society of Hematology Meeting - Poster No. 4799 |
| 09/12/2022 | American Society of Hematology Meeting - Poster No. 2673 |
| 09/12/2022 | American Society of Hematology Meeting - Abstract No. 5776 |
| 09/12/2022 | American Society of Hematology Meeting - Poster No. 4800 |
| 22/11/2022 | SEB Healthcare Seminar |
| 09/11/2022 13:00 | Q3 2022 Earnings Call |
| 09/11/2022 08:18 | Q3 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 7,60 - | 118 156 -24.22% | 8,36 6,88 21.53% | 35,2 38,8 -9.31% |
|
EBITDA Million SEK | Released Forecast Spread | -419 -421 0.46% | -735 -678 -8.39% | -1 577 -1 495 -5.51% | -1 400 -1 411 0.81% | -332 -319 -4.15% | 0,00 -241 - |
|
EBIT Million SEK | Released Forecast Spread | -419 -421 0.41% | -739 -685 -7.97% | -1 591 -1 494 -6.5% | -1 421 -1 331 -6.72% | -349 -319 -9.53% | -253 -234 -8.51% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -419 -416 -0.78% | -740 -684 -8.16% | -1 592 -1 495 -6.54% | -1 421 -1 332 -6.7% | -338 -319 -5.87% | -248 -236 -5.26% |
|
Net income Million SEK | Released Forecast Spread | -419 -416 -0.82% | -741 -684 -8.25% | -1 595 -1 481 -7.7% | -1 430 -1 302 -9.85% | -338 -319 -5.95% | -249 -236 -5.54% |
|
EPS SEK | Released Forecast Spread | -9,77 -9,88 1.11% | -14,3 -13,6 -5.76% | -25,6 -23,3 -9.75% | -19,0 -17,9 -6.31% | -4,11 -3,63 -13.13% | -2,76 -2,07 -33.18% |
| Announcement Date | 22/02/19 | 20/02/20 | 18/02/21 | 17/02/22 | 16/02/23 | 24/02/24 |
Quarterly results
| Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 54,3 93,3 -41.85% | -21,7 32,6 -166.63% | 0,00 22,7 - | 8,75 0,00 - | 0,00 0,00 - |
|
EBIT Million SEK | Released Forecast Spread | -339 -337 -0.5% | -390 -168 -131.88% | -98,9 -162 39.11% | -61,1 -66,0 7.38% | -88,9 -59,7 -48.79% |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -339 -338 -0.18% | -389 -168 -131.67% | -98,6 -162 39.28% | -59,6 -66,0 9.7% | -88,3 -59,7 -47.91% |
|
Net income Million SEK | Released Forecast Spread | -778 -338 -130.08% | -394 -168 -134.35% | -98,6 -162 39.28% | -59,8 -66,0 9.28% | -88,4 -59,7 -48.1% |
|
EPS SEK | Released Forecast Spread | -10,3 -4,49 -130.07% | -5,23 -2,22 -135.59% | -1,31 -2,15 39.07% | -0,79 -0,87 9.2% | -1,00 -0,72 -38.89% |
| Announcement Date | 24/11/21 | 17/02/22 | 04/05/22 | 11/08/22 | 09/11/22 |
More events
Past sector events for Oncopeptides AB
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ONCO Stock
- Calendar Oncopeptides AB
